Target intelligence / Profile preview

Zinc-dependent metalloprotease

Molecular classification
Enzyme, Protease, Metalloprotease
01

Overview

Zinc-dependent metalloproteases are a diverse class of enzymes that utilize a catalytic zinc ion at their active site to hydrolyze peptide bonds, chiefly within proteins of the extracellular matrix such as collagen. The zinc ion is usually held in a conserved motif by several histidine and glutamate residues, with a water molecule positioned for nucleophilic attack on the peptide substrate[1][3][5][7][8]. These enzymes play key roles in tissue remodeling, development, immune response, and pathologic processes such as cancer metastasis and bacterial toxin action. Despite many attempts, selective drug targeting has been challenging due to their structural similarity and broad physiological roles. This target name refers to an entire class, not one single protein, and should be specified further for precise therapeutic or research purposes.

Other names
MetalloproteaseMetalloproteinaseMatrix metalloproteinase (for specific subfamily)ADAMADAMTSMMP (for matrix metalloproteinases)
02

Mechanism of action

Inhibition of proteolytic activity (by chelating active-site zinc or blocking substrate binding sites) Regulation or prevention of ECM degradation Interference with cell signaling by preventing target cleavage

03

Biological functions

Protein degradation (especially extracellular matrix breakdown, e.g., collagen degradation)Cell signaling modificationMorphogenesisTissue repair and remodelingCellular invasion and migrationImmunomodulation
04

Disease associations

Cancer (tumor invasion/metastasis)Cardiovascular disease (e.g., atherosclerosis, aneurysm)InflammationInfection (e.g., bacterial toxins cleaving host pathways)Neurodegenerative disease (for some family members)
05

Safety considerations

Poor specificity (most inhibitors affect multiple metalloproteases, leading to off-target effects)Potential impairment of normal tissue remodeling, healing, or immune functionMusculoskeletal side effects with broad-spectrum MMP inhibitors
06

Interacting drugs

Doxycycline (MMP inhibitor, generic)

5 more in the full profile.

07

Biomarkers

Circulating MMP levels (for MMPs, in cancer, cardiovascular disease monitoring)Tissue/plasma protease activity

Beyond the preview

Go deeper on Zinc-dependent metalloprotease.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc-dependent metalloprotease.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call